Optimum Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$1.86K 716
2023
Q3
$1.86K Hold
100
﹤0.01% 652
2023
Q2
$2.53K Hold
100
﹤0.01% 643
2023
Q1
$2.59K Hold
100
﹤0.01% 662
2022
Q4
$2.37K Sell
100
-29
-22% -$782 ﹤0.01% 675
2022
Q3
$3K Hold
129
﹤0.01% 704
2022
Q2
$4K Hold
129
﹤0.01% 716
2022
Q1
$9K Hold
129
﹤0.01% 665
2021
Q4
$12K Buy
129
+100
+345% +$12K ﹤0.01% 663
2021
Q3
$4K Hold
29
﹤0.01% 765
2021
Q2
$5K Sell
29
-104
-78% -$16.9K ﹤0.01% 819
2021
Q1
$24K Hold
133
0.01% 640
2020
Q4
$27K Buy
133
+29
+28% +$5.9K 0.01% 584
2020
Q3
$23K Hold
104
0.01% 585
2020
Q2
$20K Sell
104
-451
-81% -$79K 0.01% 605
2020
Q1
$86K Buy
+555
New +$64.6K 0.04% 335

Other funds holding TDOC

Optimum Investment Advisors's TDOC Position: Q4 2023 in Review

Optimum Investment Advisors sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 100 shares — an estimated $1.86K sold.

Optimum Investment Advisors first reported a position in TDOC in Q1 2020 and held it in 15 quarters. The position peaked at $86K in Q1 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Optimum Investment Advisors reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Optimum Investment Advisors sold 100 Teladoc Health shares in Q4 2023, an estimated $1.86K.
  • Optimum Investment Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 15 quarters.
  • Optimum Investment Advisors's Teladoc Health position peaked at $86K in Q1 2020.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Optimum Investment Advisors's 13F filing for Q4 2023, filed 8 Jan 2024.